Literature DB >> 27254269

Molecular markers in pituitary tumors.

Asha M Robertson1, Anthony P Heaney.   

Abstract

PURPOSE OF REVIEW: This review summarizes our current understanding of the mechanisms and factors involved in pituitary tumorigenesis. It provides a comprehensive review on the role of genetic mutations, epigenetics, oncogenes, tumor suppressor genes, cell cycle deregulation, and highlights recent findings of altered micro-RNA and long noncoding RNA expression in pituitary tumors. RECENT
FINDINGS: This article provides a concise summary of our knowledge regarding oncogenes, tumor suppressor genes, and cell cycle deregulation in pituitary tumors. Additionally, it highlights new findings in epigenetics and altered micro-RNA and long noncoding RNA expression in pituitary tumors.
SUMMARY: Improved understanding of the mechanism(s) and candidates implicated in pituitary tumorigenesis may result in the identification of new therapeutic targets in pituitary tumors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27254269     DOI: 10.1097/MED.0000000000000266

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  7 in total

1.  Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas.

Authors:  Jung Soo Lim; Mi-Kyung Lee; Eunhee Choi; Namki Hong; Soo Il Jee; Sun Ho Kim; Eun Jig Lee
Journal:  Endocrine       Date:  2018-11-24       Impact factor: 3.633

2.  Genome-wide analysis of differentially expressed lncRNAs and mRNAs in primary gonadotrophin adenomas by RNA-seq.

Authors:  Jiye Li; Chuzhong Li; Jianpeng Wang; Guidong Song; Zheng Zhao; Haoyuan Wang; Wen Wang; Hailong Li; Zhenye Li; Yazhou Miao; Guilin Li; Yazhuo Zhang
Journal:  Oncotarget       Date:  2017-01-17

3.  Targeting the ERK pathway for the treatment of Cushing's disease.

Authors:  Dongyun Zhang; Marvin Bergsneider; Marilene B Wang; Anthony P Heaney
Journal:  Oncotarget       Date:  2016-10-25

4.  Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model.

Authors:  Sen Cheng; Jiaqi Wu; Chuzhong Li; Yangfang Li; Chunhui Liu; Guilin Li; Wuju Li; Shuofeng Hu; Xiaomin Ying; Yazhuo Zhang
Journal:  J Transl Med       Date:  2019-05-20       Impact factor: 5.531

Review 5.  Molecular Network Basis of Invasive Pituitary Adenoma: A Review.

Authors:  Qi Yang; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-24       Impact factor: 5.555

6.  Molecular Markers of Telomerase Complex for Patients with Pituitary Adenoma.

Authors:  Greta Gedvilaite; Alvita Vilkeviciute; Brigita Glebauskiene; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  Brain Sci       Date:  2022-07-25

7.  LncRNA SNHG6 Induces Epithelial-Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944.

Authors:  Dandan Mao; Yuanqing Jie; Yao Lv
Journal:  Cancer Biother Radiopharm       Date:  2020-09-16       Impact factor: 3.632

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.